Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic properties of fenbufen.

S S Kerwar

    The American Journal of Medicine
    |October 31, 1983
    PubMed
    Summary

    Fenbufen is an anti-inflammatory drug that acts as a prodrug, with its metabolite inhibiting prostaglandin synthesis. This mechanism contributes to its potent anti-inflammatory effects and low ulcerogenic potential.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A new structural class of proteasome inhibitors that prevent NF-kappa B activation.

    Biochemical pharmacology·1999
    Same author

    CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation.

    The Journal of biological chemistry·1997
    Same author

    Attenuation of interleukin 2-induced pulmonary vascular leak syndrome by low doses of oral methotrexate.

    Cancer research·1995
    Same author

    Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2.

    Cellular immunology·1995
    Same author

    A fluorescence assay for geranylgeranyl transferase type I.

    Analytical biochemistry·1995
    Same author

    Induction of collagenase synthesis in chondrocytes by a factor synthesized by inflamed synovial tissue. 1984.

    Agents and actions·1994

    Area of Science:

    • Pharmacology
    • Drug Metabolism

    Background:

    • Fenbufen (Cinopal) is an orally active nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties.
    • NSAIDs are widely used for their anti-inflammatory effects, but often carry risks of gastrointestinal side effects like ulcers.

    Purpose of the Study:

    • To investigate the mechanism of action of fenbufen.
    • To evaluate the anti-inflammatory and analgesic properties of fenbufen.
    • To assess the ulcerogenic potential of fenbufen in comparison to other NSAIDs.

    Main Methods:

    • Laboratory tests in various animal models (mice, rats, guinea pigs, dogs) to assess anti-inflammatory and analgesic activity.
    • Mechanistic studies to determine fenbufen's effect on cyclooxygenase activity and prostaglandin synthesis.
    • Comparative studies in the type II collagen arthritis model.

    Main Results:

    • Fenbufen demonstrated a long duration of anti-inflammatory and analgesic activity across multiple species.
    • Fenbufen itself showed no intrinsic cyclooxygenase inhibition; its metabolite, biphenylacetic acid, was identified as a potent inhibitor of prostaglandin synthesis.
    • Fenbufen exhibited a low ulcerogenic potential, attributed to its prodrug nature.
    • Comparative studies showed fenbufen to be more potent than sulindac in the type II collagen arthritis model.

    Conclusions:

    • Fenbufen functions as a prodrug, with its active metabolite responsible for potent anti-inflammatory and analgesic effects.
    • The prodrug mechanism of fenbufen contributes to a favorable anti-inflammatory to ulcerogenic ratio, reducing gastrointestinal risks.
    • Fenbufen exhibits superior anti-inflammatory potency compared to sulindac in an arthritis model.

    Related Experiment Videos